Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $747.7700 (-0.27%) ($747.7700 - $749.4900) on Thu. May. 18, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.54% (three month average) | RSI | 28 | Latest Price | $747.7700(-0.27%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.1% a day on average for past five trading days. | Weekly Trend | REGN declines -2.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(49%) XLV(45%) DIA(31%) SPLV(29%) VYM(29%) | Factors Impacting REGN price | REGN will decline at least -0.77% in a week (0% probabilities). VXX(-24%) VIXM(-19%) UUP(-4%) TBT(-4%) ACES(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.77% (StdDev 1.54%) | Hourly BBV | 0.2 () | Intraday Trend | 0% | | | |
|
Resistance Level | $769.51 | 5 Day Moving Average | $746.74(0.14%) | 10 Day Moving Average | $749.4(-0.22%) | 20 Day Moving Average | $769.51(-2.83%) | To recent high | -9.9% | To recent low | 0.8% | Market Cap | $79.285b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |